By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Kedrion S.p.A. 

Loc. Ai Conti

Castelvecchio Pascoli  Lucca  55020  Italy
Phone: 39-0583-19691 Fax: 39-0583-766121


SEARCH JOBS








Company News
Kedrion And Kamada Ltd. (KMDA) Announce FDA Acceptance Of BLA Submission For Human Rabies Immunoglobulin As A Post-Exposure Treatment 11/7/2016 9:09:44 AM
Kamada Ltd. (KMDA) And Kedrion Seek FDA Approval Of Human Rabies Immunoglobulin As A Post-Exposure Treatment 9/1/2016 11:13:01 AM
Kedrion Receives FDA Approval To Package Koate Double Viral Inactivation (DVI) Antihemophilic Factor (Human) With Mix2Vial Needle-Free Transfer Device 3/28/2016 8:17:47 AM
Kedrion S.p.A. Continues Global Expansion With Dedication Ceremony At United States Facility 5/18/2015 9:22:18 AM
Entegrion Announces Kedrion S.p.A. Collaboration to Develop Blood Product Technology 3/19/2013 11:45:32 AM
Kedrion S.p.A. Launches US Subsidiary with Acquisition of Koate(R)-DVI 6/13/2011 1:29:35 PM
ProMetic Life Sciences Inc. (PFSCF.PK) Announces Signature of Definitive License Agreement With Kedrion S.p.A. for Two Hyperimmune Products 2/27/2008 6:44:50 AM
ProMetic Life Sciences Inc. (PFSCF.PK) Announces Signature of Definitive License Agreement With Kedrion S.p.A. for Two Hyperimmune Products 2/26/2008 9:36:25 AM
ProMetic Life Sciences Inc. (PFSCF.PK) Announces Signature of Definitive License Agreement with Kedrion S.p.A. for Two Hyperimmune Products 2/26/2008 6:42:41 AM
Life Therapeutics Ltd. (LFE.AX) to Appoint Independent Expert to Value Kedrion S.p.A. Transaction 8/17/2007 11:14:25 AM
12
//-->